myirislogo
06 July, 2015 04:47 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Hindalco In 110.55 0.54
State Bank O 268.85 0.54
Reliance 1006.75 0.35
Tata Stl 300.95 1.13
Icici Bank 314.35 0.45
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Dr Datsons Labs Limited
Dr Datsons Labs Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:33412NSE:DRDATSONSBloomberg:AALL@INReuters:AANJ.BO
Market Lot: 1Face Value: 10ISIN Demat: INE928K01013
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
12-MAR-15 Dr Datson Labs has forged a potential collaboration with Delhi based pharma company Ochoa Laboratories to produce oncology drugs to cater to the European market worth Rs 1.20 billion. 09-MAR-15 Indian drug maker Datsons Labs specializing in manufacturing of anti-malarial drugs has received the proposal to supply the artemesinin-based combination therapies (ACTs) to the Clinton Health Access Initiative (CHAI), the healthcare project ...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Dr. Datsons Labs to partner with Clinton Foundation   -IRIS 09-Mar-15
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2014(9)31-Mar-2014 (12)31-Mar-2012 (12)
Net sales 4865.854210.544799.64
Other Income92.8578.7123.57
Total Income4958.704289.254823.21
Cost of goods sold4657.393640.023745.59
OPBDIT301.31649.231077.62
PAT1.006.74410.29
Gross Block---
Equity capital1052.59316.55138.87
EPS (Rs.)-0.1934.42
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-155.79 - 4477.376.51 - 17.40
Debt / Equity (x)---
Operating margin (% of OI) 6.115.122.3
Net margin (% of OI) 0.0 0.2 8.5
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Plot No 34, Aanjaneya House
Postal Colony
Chembur
Mumbai
Maharashtra-400 071
PHONE
(022) 2526 4500 / 2524 3678
FAX
(022) 2526 2890 / 2522 3251 / 2526 2867
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer